Skip to main content
All lobbying filings

SIGHTLINE ADVOCACY, LLC

Lobbying for AMGEN · Biotechnology

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $20,000.00 income · posted Jul 20, 2026

Official filing document

 Lobbying activity 1
Health Issues

Issues related to drug pricing; Issues related to cardiovascular disease awareness and treatment.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem